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To the Editor: We read with interest the study by Noh et al., 
which demonstrated that the duration of diabetes could be a 
marker for left ventricular (LV) diastolic dysfunction, inde-
pendent of other diastolic dysfunction-related variables in 
type 2 diabetic patients without hypertension or ischemic 
heart disease [1]. 
  Diabetic cardiomyopathy is diabetes-associated changes in 
the structure and function of the myocardium that are not di-
rectly attributable to other confounding factors, such as coro-
nary artery disease. It is characterized by a latent subclinical 
period, during which there is evidence of diastolic dysfunction 
and left ventricular hypertrophy before overt clinical deterio-
ration and systolic failure ensue [2]. 
  Noh’s study demonstrated that diabetes duration is an inde-
pendent risk factor of LV diastolic dysfunction in a Korean 
population with type 2 diabetes.
  Noh’s study included type 2 diabetic patients with normal 
ECG and without history of ischemic heart disease. However, 
many diabetic patients have asymptomatic coronary heart dis-
ease. Thus, screening patients with only past medical history 
and normal resting ECG could limit the value of excluding pa-
tients with ischemic heart disease. Incorporating exercise test-
ing into patient selection could provide more ideal study sub-
jects [3].
  Previous studies reported that LV diastolic dysfunction in 
diabetic patients is also associated with hyperglycemia, dura-
tion of diabetes, insulin resistance, and obesity [2,4]. Noh’s 
study showed that higher body mass index and longer dura-
tion of diabetes were associated with LV diastolic dysfunction 
in patients with type 2 diabetes. These findings were consistent 
with the previous reports. Diastolic dysfunction is believed to 
be the earliest functional change in diabetic cardiomyopathy 
and is closely correlated with glycated haemoglobin [4]. Hy-
perglycaemic patients demonstrate an 8% increase in the risk 
of developing heart failure with every 1% elevation of glycosy-
lated hemoglobin [4]. However, in authors’ study, there was no 
significant difference in the level of HbA1c between the two 
groups. The small number of study subjects is one possible ex-
planation for the negative result. Another is relatively poor 
glycemic control in both groups. Comparison of LV diastolic 
dysfunction between patients with good glycemic control 
(HbA1C < 7%) and patients with poor glycemic control 
(HbA1C ≥ 7%) is necessary to examine the association of gly-
cemic control and LV diastolic dysfunction.
  Echocardiography was used as a tool to diagnos LV dys-
function. A recent study showed that asymptomatic diabetic 
patients, even with normal resting LV dimensions and func-
tion, experience exercise-induced delayed onset of LV relax-
ation [5]. Although the predictive value of echocardiography 
for LV dysfunction is good, it might have not ruled out LV 
dysfunction completely. Therefore, stress tests, such as tread-
mill or dobutamine stress echocardiography, could detect 
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more patients with LV dysfunction.
  Increased LV mass is an independent risk factor for heart 
failure in type 2 diabetes, and may contribute to reduced myo-
cardial compliance [6,7]. Thus, it would be more interesting to 
mention the association between LV mass and heart failure in 
the authors’ study.
  Considering the high prevalence and significant morbidity 
and mortality of heart failure in patients with type 2 diabetes, 
the evaluation of cardiac function in asymptomatic diabetic 
patients is very important to detect and prevent heart failure.
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